JAK inhibitor Delgocitinib, Purity ≥98%

Cat. No.: X23-10-ZQ374

JAK inhibitor Delgocitinib, Purity ≥98%

Synonym: Delgocitinib; 1263774-59-9; JTE-052; JTE-052A; Corectim; LEO 124249A; LEO 124249; JAK inhibitor

  • CAS Number: 1263774-59-9
  • Compound CID: 50914062
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Delgocitinib is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, and TYK2.
Molecular Weight
310.35
Molecular Formula
C16H18N6O
Targets
JAK1: 2.8 nM; JAK2: 2.6 nM; JAK3: 13 nM; TYK2: 58 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Delgocitinib can be employed to study JAK inhibition and its effects in dermatological and inflammatory conditions.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0